ClinicalTrials.govEU Clinical Trials Register
# CTID Title Phase Status Date
1 NCT03866174 A Study of Psilocybin for Major Depressive Disorder (MDD) 2 Not yet recruiting 2019-05-22
2 NCT03181529 Effects of Psilocybin in Major Depressive Disorder 2 Active, not recruiting 2019-05-20
3 NCT02950467 Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors 1 Active, not recruiting 2019-05-17
4 NCT02421263 The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals 1 Recruiting 2019-05-08
5 NCT03715127 Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients – Proof of Concept 2 Recruiting 2019-05-02
6 NCT02061293 A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence 2 Recruiting 2019-04-26
7 NCT03554174 Psilocybin – Induced Neuroplasticity in the Treatment of Major Depressive Disorder 1 Recruiting 2019-04-17
8 NCT03604744 Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin 1 Recruiting 2019-03-29
9 NCT03429075 Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms 2 Recruiting 2019-02-28
10 NCT03300947 Psilocybin for Treatment of Obsessive Compulsive Disorder 1 Recruiting 2019-02-26
11 NCT03341689 Psilocybin for the Treatment of Migraine Headache Recruiting 2019-01-31
12 NCT00957359 Psilocybin Cancer Anxiety Study Active, not recruiting 2019-01-30
13 NCT03806985 Effects of Psilocybin in Post-Traumatic Headache Recruiting 2019-01-14
14 NCT02981173 Psilocybin for the Treatment of Cluster Headache Recruiting 2018-12-18
15 NCT03775200 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression Not yet recruiting 2018-12-12
16 NCT03356483 Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. Recruiting 2018-11-13
17 NCT03736980 Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self Active, not recruiting 2018-11-08
18 NCT02243813 Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion Recruiting 2018-10-10
19 NCT02971605 Persisting Effects of Psilocybin Completed 2018-08-28
20 NCT00465595 Psychopharmacology of Psilocybin in Cancer Patients Completed 2018-06-19
21 NCT02037126 Psilocybin-facilitated Treatment for Cocaine Use 2 Recruiting 2018-06-13
22 NCT03380442 Psilocybin and Depression 2 Not yet recruiting 2017-12-15
23 NCT03289949 The Neurobiological Effect of 5-HT2AR Modulation 1 Recruiting 2017-09-20
24 NCT02163707 UW Psilocybin Pharmacokinetics Study 1 Completed 2017-04-19
25 NCT00802282 Psilocybin and Spiritual Practice 1 Completed 2016-02-23
26 NCT00979693 Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma 2 Withdrawn 2014-09-16
27 NCT01988311 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators 1 Completed 2014-05-19
28 NCT01534494 Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence 2 Unknown status 2014-02-06
29 NCT00302744 Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety 1 Completed 2013-01-28
EudraCT Title Phase Status Date
2017-003288-36 The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD) 2 Ongoing 2018-07-17
2017-000219-18 Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms 2 Ongoing 2018-06-22
2017-003288-36 The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD) 2 Ongoing 2018-01-24
2017-003288-36 The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD) 2 Ongoing 2017-10-19
2013-003196-35 Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study 2 Completed 2015-07-01
2012-004579-37 Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI 1,2 Ongoing 2014-01-02